Literature DB >> 8216378

Effects of flavonoids on the release of reactive oxygen species by stimulated human neutrophils. Multivariate analysis of structure-activity relationships (SAR).

B Limasset1, C le Doucen, J C Dore, T Ojasoo, M Damon, A Crastes de Paulet.   

Abstract

In the present study we measured the inhibition by 34 compounds, either flavonoids or related substances, of the release of reactive oxygen species by human neutrophils after stimulation by three agents: the bacterial peptide N-fMetLeuPhe (FMLP), the protein kinase C activator phorbol myristate acetate (PMA) or opsonized zymosan (OZ), using two chemiluminescent probes, lucigenin or luminol in the presence or absence of horseradish peroxidase (HRP). The data matrix (34 x 7) was submitted to multivariate analysis: first, a correspondence factorial analysis to uncover levels of correlation among the biochemical parameters and the specificity of action of the test-compounds and second, a minimum spanning tree analysis that classified the chemical structures into a network describing both specificity and amplitude of the inhibition of the chemiluminescence response. The major conclusions of the analyses were: (a) opposition between inhibition of poly-morphonuclear leukocytes (PMNs) stimulated by FMLP and of PMNs stimulated by PMA or OZ implying that, for the molecules under study, there was a fundamental difference in the manner in which this inhibition occurred and, conversely, a difference in the nature of the stimulatory action of these activators. Molecules lacking hydroxyl groups on ring B, i.e. chrysin, chalcone, flavone and galangin, molecules glycosylated in position 7, i.e. hesperidin and naringin and ring B mono-hydroxylated molecules were, for the most part, at the origin of this dichotomy and might interfere with the membrane FMLP receptor; (b) a marked difference in chemiluminescence inhibition in the presence or absence of HRP that can be explained by the differential action of catechins compared to flavone and flavonol derivatives; (c) a similarity in biological profile between non-flavonoids such as chalcone and phloretin and low mean-activity flavonoids such as chrysin and galangin and between the non-flavonoid curcumin and the highly active flavonoid isorhamnetin; (d) a reaffirmation of the importance of ring A (C5,7) and ring B (C3',4') dihydroxylation, ring C (C3) hydroxylation, but also of the presence of a methoxy group on ring B in engendering high potency. This potency is generally decreased by C2-C3 saturation and by glycosylation. The most active molecules identified in this study provide valuable information for the selection of simpler molecules (e.g. metabolites accounting for the potency of orally administered flavonoids) for further structure-activity relationship (SAR) studies that could lead to the design of novel drugs or prodrugs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8216378     DOI: 10.1016/0006-2952(93)90476-d

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

1.  Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol.

Authors:  S H Tsai; S Y Lin-Shiau; J K Lin
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

2.  Hypochlorous acid scavenging properties of local Mediterranean plant foods.

Authors:  Sebastian Schaffer; Gunter P Eckert; Walter E Müller; Rafael Llorach; Diego Rivera; Simona Grande; Claudio Galli; Francesco Visioli
Journal:  Lipids       Date:  2004-12       Impact factor: 1.880

3.  Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.

Authors:  Andrei I Khlebnikov; Igor A Schepetkin; Nina G Domina; Liliya N Kirpotina; Mark T Quinn
Journal:  Bioorg Med Chem       Date:  2006-11-29       Impact factor: 3.641

Review 4.  Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Liliya N Kirpotina; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2015-09-15       Impact factor: 4.932

Review 5.  Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease.

Authors:  Ana García-Lafuente; Eva Guillamón; Ana Villares; Mauricio A Rostagno; José Alfredo Martínez
Journal:  Inflamm Res       Date:  2009-04-21       Impact factor: 4.575

6.  Effects of compounds extracted from Santolina oblongifolia on TXB(2) release in human platelets.

Authors:  A M Silván; M J Abad; P Bermejo; A Villar
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

7.  Pharmacological regulation of neutrophil activity and apoptosis: Contribution to new strategy for modulation of inflammatory processes.

Authors:  Viera Jančinová; Tomáš Perečko; Radomír Nosáĺ; Danica Mihalová; Katarína Bauerová; Katarína Drábiková
Journal:  Interdiscip Toxicol       Date:  2011-03

8.  De novo biosynthesis of myricetin, kaempferol and quercetin in Streptomyces albus and Streptomyces coelicolor.

Authors:  Laura Marín; Ignacio Gutiérrez-Del-Río; Rodrigo Entrialgo-Cadierno; Claudio J Villar; Felipe Lombó
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

Review 9.  Interactions of flavones and other phytochemicals with adenosine receptors.

Authors:  Kenneth A Jacobson; Stefano Moro; John A Manthey; Patrick L West; Xiao-Duo Ji
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

10.  Chemical constituents from the rhizomes of Smilax glabra and their antimicrobial activity.

Authors:  Shuo Xu; Ming-Ying Shang; Guang-Xue Liu; Feng Xu; Xuan Wang; Cheng-Chao Shou; Shao-Qing Cai
Journal:  Molecules       Date:  2013-05-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.